Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 May 25;7(5):e015680.
doi: 10.1136/bmjopen-2016-015680.

The SUPER study: protocol for a randomised controlled trial comparing follicle-stimulating hormone and clomiphene citrate for ovarian stimulation in intrauterine insemination

Affiliations
Randomized Controlled Trial

The SUPER study: protocol for a randomised controlled trial comparing follicle-stimulating hormone and clomiphene citrate for ovarian stimulation in intrauterine insemination

N A Danhof et al. BMJ Open. .

Abstract

Objective: To study the effectiveness of four cycles of intrauterine insemination (IUI) with ovarian stimulation (OS) by follicle-stimulating hormone (FSH) or by clomiphene citrate (CC), and adherence to strict cancellation criteria.

Setting: Randomised controlled trial among 22 secondary and tertiary fertility clinics in the Netherlands.

Participants: 732 women from couples diagnosed with unexplained or mild male subfertility and an unfavourable prognosis according to the model of Hunault of natural conception.

Interventions: Four cycles of IUI-OS within a time horizon of 6 months comparing FSH 75 IU with CC 100 mg. The primary outcome is ongoing pregnancy conceived within 6 months after randomisation, defined as a positive heartbeat at 12 weeks of gestation. Secondary outcomes are cancellation rates, number of cycles with a monofollicular or with multifollicular growth, number of follicles >14 mm at the time of ovulation triggering, time to ongoing pregnancy, clinical pregnancy, miscarriage, live birth and multiple pregnancy. We will also assess if biomarkers such as female age, body mass index, smoking status, antral follicle count and endometrial aspect and thickness can be used as treatment selection markers.

Ethics and dissemination: The study has been approved by the Medical Ethical Committee of the Academic Medical Centre and from the Dutch Central Committee on Research involving Human Subjects (CCMO NL 43131-018-13). Results will be disseminated through peer-reviewed publications and presentations at international scientific meetings.

Trial registration number: NTR4057.

Keywords: Unexplained subfertility; clomiphene citrate; follicle stimulating hormone; intra uterine insemination; mild male factor subfertility; ovarian stimulation.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Flowchart of study. CC, clomiphene citrate; FSH, follicle-stimulating hormone; ICI, intracervical insemination; IUI, intrauterine insemination; OS, ovarian stimulation; TMSC, total motile sperm count.

References

    1. Boivin J, Bunting L, Collins JA, et al. . International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod 2007;22:1506–12. 10.1093/humrep/dem046 - DOI - PubMed
    1. Verhulst SM, Cohlen BJ, Hughes E, et al. . Intra-uterine insemination for unexplained subfertility. Cochrane Database Syst Rev 2006:CD001838 10.1002/14651858.CD001838.pub3 - DOI - PubMed
    1. van Rumste MM, Custers IM, van der Veen F, et al. . The influence of the number of follicles on pregnancy rates in intrauterine insemination with ovarian stimulation: a meta-analysis. Hum Reprod Update. 2008;14:563–70. 10.1093/humupd/dmn034 - DOI - PubMed
    1. Cantineau AEP, Cohlen BJ. Ovarian stimulation protocols anti-oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertility. Cochrane Database Syst Rev 2009. - PubMed
    1. Diamond MP, Richar SL, Coutifaris C, et al. . Letrozole, gonadotropin, or clomiphene for unexplained infertility. N Engl J Med 2015:373. - PMC - PubMed

Publication types

LinkOut - more resources